News & Updates
Articles, Research
Blood Pressure Drug Can Reduce Arterial Stiffening
Obesity is closely intertwined with high blood pressure and diabetes, often putting patients at greater risk for either of these health conditions.
Articles, Research
New Grant Supports Study of Cardiac Deterioration
Cardiovascular-kidney-metabolic (CKM) syndrome is a newly recognized disorder, first defined in 2023 by the American Heart Association, that is systemic, progressive and often fatal.
Articles, Research
Mizzou’s Bench-to-Bedside Efforts Support a New Drug for a Neuromuscular Disorder with No Cure
The drug, ignaseclant, helped people with Charcot-Marie-Tooth disease in a clinical trial at Mizzou’s NextGen Precision Health building.
Events
Cancer Science Seminar: May 21, 2026
“Peptide-Targeted Mesoporous Silicon Nanoparticles for Delivery of Biologics to Tumors,” presented by Micheal Sailor, May 21 at 4:30 pm
Reproduction Science Seminar: June 3, 2026
"TBD," presented by Zhihua Jiang, PhD, June 3 at 4pm
Clinical Research Study Coordinator Bootcamp: June 5, 2026
A full day training designed to provide basic knowledge that is beneficial for research coordinators and staff. The program includes lectures, interactive activities, and breakout group exercises.
Researchers
NextGen Precision Health investigators and their lab teams are dedicated to delivering the next generation of personalized health care solutions. They’ve been recruited from around the world to align their efforts across disciplines in pursuit of improved health outcomes for Missourians and beyond.

World-class research spaces
The Roy Blunt NextGen Precision Health building accelerates innovations in precision health care for Missourians and the world.

A System of Strengths
Mizzou, the University of Missouri–Kansas City, Missouri University of Science and Technology and the University of Missouri–St. Louis each have unique research focuses and resources contributing to the NextGen Precision Health initiative. Working with University of Missouri Health Care, MU Extension and private partners, researchers are exploring precision health solutions for society's toughest diseases.
